No Data
No Data
Express News | Sws Hemodialysis Care Says Shareholders Plan to Unload up to 4% Stake in Three Months
Shanwaishan (688410.SH): has not been involved in the manufacturing of deionized water equipment related to Integrated Circuits PCB and other businesses.
On April 30, Glonghui stated on the interactive platform that Shanwaishan (688410.SH) is a national high-tech enterprise that integrates blood purification equipment, blood purification consumables, intelligent management systems for blood purification centers, and chain dialysis centers. It provides comprehensive blood purification solutions for Global kidney disease and critically ill patients, focusing on the blood purification segment of medical instruments. Currently, the company has not engaged in Business related to the manufacturing of deionized water equipment like Integrated Circuits PCBs.
Shanwai Mountain (688410.SH): The DeepSeek large model has not yet been deployed locally.
On April 30, Gelonghui reported that Shanwaishan (688410.SH) stated on the interactive platform that the company has not yet locally deployed the DeepSeek large model. Currently, the company encourages employees to learn and use DeepSeek through public channels to improve work efficiency. The company will continue to focus on the development of AI large model technologies like DeepSeek and actively explore diverse cooperation opportunities.
SWS Hemodialysis Care's (SHSE:688410) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Direct coverage of the Star medical instruments industry collective Earnings Conference: Multiple companies are laying out AI medical Business, and key segments in innovation fields may accelerate the development of domestic production.
① Attending companies believe that tariff policies will bring some cost pressures and market challenges to enterprises, but at the same time, it has accelerated the localization process in relevant fields; ② Some attending companies disclosed the latest developments in their Business during the earnings briefing and the planning for related lines by 2025.
Investors Will Want SWS Hemodialysis Care's (SHSE:688410) Growth In ROCE To Persist